Heron Therapeutics to Report Second Quarter 2025 Financial Results on Monday, August 11, 2025
The conference call can be accessed by phone by utilizing the following registration link which will provide participants with dial-in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The conference call will also be available via webcast under the Investor Relations section of Heron's website at www.herontx.com. An archive of the teleconference and webcast will also be made available on Heron's website for 60 days following the call.
About Heron Therapeutics, Inc.
Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. For more information, visit www.herontx.com.
Forward-looking Statements
This news release contains 'forward-looking statements' as defined by the Private Securities Litigation Reform Act of 1995. Heron cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, but are not limited to, risks and uncertainties identified in the Company's filings with the Securities and Exchange Commission. Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or revise these statements except as may be required by law.
Investor Relations and Media Contact:
Ira Duarte
Executive Vice President, Chief Financial Officer
Heron Therapeutics, Inc.
[email protected]
858-251-4400
View original content to download multimedia: https://www.prnewswire.com/news-releases/heron-therapeutics-to-report-second-quarter-2025-financial-results-on-monday-august-11-2025-302515450.html
SOURCE Heron Therapeutics, Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
BlueLinx Holdings Inc (BXC) Q2 2025 Earnings Call Highlights: Navigating Market Challenges with ...
Net Sales: $780 million, up 2% year over year. Adjusted EBITDA: $26.8 million, representing a 3.4% adjusted EBITDA margin. Adjusted Net Income: $5.6 million or $0.70 per share. Gross Margin: 15.3%, down 60 basis points from the prior period. Specialty Products Net Sales: $543 million, up 1% year over year. Specialty Products Gross Margin: 18.5%, down 80 basis points from last year. Structural Products Net Sales: $237 million, up 3.4% compared to the prior year period. Structural Products Gross Margin: 8.2%, up 30 basis points from the same period last year. Cash on Hand: $387 million at the end of the quarter. Total Debt: $376 million, with a net debt of negative $11 million. Operating Cash Flow: Negative $27 million for the quarter. Free Cash Flow: Negative $36 million for the quarter. Share Repurchase: $20 million repurchased in Q2, with a new $50 million authorization approved. Warning! GuruFocus has detected 3 Warning Signs with BXC. Release Date: July 30, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points BlueLinx Holdings Inc (NYSE:BXC) reported solid gross margins for both specialty and structural products, with net sales and volumes increasing despite challenging market conditions. The company successfully executed its product and channel strategies, resulting in market share gains and strong demand creation efforts, particularly in the multi-family segment. BlueLinx Holdings Inc (NYSE:BXC) returned capital to shareholders by repurchasing $20 million of shares in Q2 and authorized a new $50 million share repurchase program. The company's digital transformation efforts are on track, with advancements in Oracle transportation management and e-commerce transactions, enhancing operational efficiencies. BlueLinx Holdings Inc (NYSE:BXC) maintained a strong financial position with significant liquidity, allowing flexibility in strategic initiatives and capital allocation. Negative Points Market-driven price deflation continues to impact profitability, particularly in certain product categories, despite volume growth. The housing market remains soft, with high mortgage rates and economic uncertainty affecting the building materials and distribution sector. The multi-family segment, while growing, leads to longer inventory holding periods and lower gross margins due to direct sales dynamics. Competitive pressures in the market require BlueLinx Holdings Inc (NYSE:BXC) to work harder to maintain and grow its business. The company's free cash flow was negative in Q2, primarily due to lower net income, seasonal working capital changes, and increased capital expenditures. Q & A Highlights Q: How did specialty volumes trend throughout the quarter, given the slower than expected builder spring selling season? A: Shyamsundar Reddy, CEO, explained that despite a 10% year-over-year decline in housing starts, BlueLinx's strategy to create demand through multi-family and builder pull-through efforts is working. They focused on engineered wood products (EWP), millwork, and structural product categories to drive growth, supporting customers and suppliers in achieving their growth objectives. Q: Can you provide more color on the primary drivers of the strong multi-family growth and the runway for continued share gains? A: Shyamsundar Reddy, CEO, noted that early investments in multi-family projects have paid off, providing a seasonal catalyst. BlueLinx has made both operational and capital investments to support the complexity of multi-family projects, working closely with key customers to win business. They leverage their team and services to support customers, offering creative program structures that benefit suppliers, customers, and BlueLinx. Q: Has the success of the Portland Greenfield accelerated the timeline for future greenfields, especially in key Western markets? A: Shyamsundar Reddy, CEO, stated that while the success of the Portland Greenfield accelerates their ability to have successful future greenfields, the main constraint is finding the right real estate. BlueLinx has an active greenfield market pipeline and is committed to opening more greenfields, working with real estate professionals to identify sites. Q: Are there any recent changes in broader industry conditions or competition? A: Shyamsundar Reddy, CEO, mentioned that while there is more certainty regarding tariffs, which could unlock pent-up demand, there are no significant changes beyond public information. Competition remains intense, but BlueLinx is controlling the narrative by driving demand through investments in new channel focus areas. Q: How does BlueLinx manage the risk of commodity volatility in multi-family projects? A: Shyamsundar Reddy, CEO, explained that BlueLinx has built a robust system for managing structural wood products, leveraging consigned and cash-on-hand inventory. They maintain strong planning and relationships with customers to manage volatility, focusing on turn days for committed inventory and evolving arrangements to ensure win-win scenarios for customers, suppliers, and BlueLinx. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.
Yahoo
20 minutes ago
- Yahoo
Apollo Commercial Real Estate Finance Inc (ARI) Q2 2025 Earnings Call Highlights: Strong Loan ...
Distributable Earnings: $36 million or $0.26 per share for the second quarter. GAAP Net Income: $18 million or $0.12 per diluted share. Loan Portfolio Carrying Value: $8.6 billion, up from $7.7 billion in Q1. Weighted Average Unlevered Yield: 7.8%. New Loan Originations: $1.4 billion in commitments for the quarter. Add-on Fundings: $394 million for previously closed loans. Repayments and Sales: $631 million during the quarter. General CECL Allowance Increase: $3.1 million. Total Liquidity: $208 million at quarter end. Book Value Per Share: $12.59, excluding general CECL allowance and depreciation. Warning! GuruFocus has detected 9 Warning Signs with ARI. Release Date: July 30, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Apollo Commercial Real Estate Finance Inc (NYSE:ARI) delivered strong performance in Q2 2025, with significant progress in loan originations, portfolio management, and balance sheet optimization. ARI committed to $1.4 billion in new loans during the quarter, with year-to-date commitments reaching $2 billion, showcasing robust capital redeployment. The company benefits from Apollo's real estate credit platform, allowing access to a diverse transaction flow and eliminating cash drag. Approximately 2/3 of residential loans in ARI's portfolio have been originated in the past 24 months, benefiting from a valuation reset and enhanced credit quality. ARI successfully refinanced its Term Loan B facilities, extending corporate debt maturity to June 2029, highlighting market confidence in the company. Negative Points The carrying value of ARI's portfolio increased by 12% from the prior quarter, but the book value per share decreased slightly to $12.59. Despite progress, some assets like the Brook are still non-earning, with plans to monetize them not expected until early next year. The general CECL allowance increased by $3.1 million due to portfolio growth, indicating potential risk exposure. Leverage remains around 4 times, with significant non-earning assets, raising concerns about future leverage management. The office sector remains challenging, with ARI avoiding new office deals due to market conditions and portfolio concentration concerns. Q & A Highlights Q: How is the progress at the Brook, and what is the timeline for generating cash flow and potentially moving on from the asset? A: The Brook is a 500-plus unit development, with 70% market rate and 30% affordable units. Leasing has started on the market rate side, and the asset is expected to become cash flow positive early next year. A decision on whether to sell outright or bring in a partner is anticipated between the first and second quarter of next year. The ultimate plan is to monetize and move on. - Stuart Rothstein, CEO Q: Can you provide more details on the potential upside from the land parcels associated with the Brook? A: There is a small parcel referred to as the Western parcel, and discussions are ongoing about acquiring air rights or the assets outright to increase density. If successful, this could provide upside for ARI shareholders, but it is too early to predict the outcome. - Stuart Rothstein, CEO Q: What are your expectations for the commercial real estate transaction market through the end of the year, and how does it affect ARI's plans? A: Activity has picked up, and there is more capital and deal flow. We are confident in finding opportunities that fit ARI's goals. The market is expected to remain robust, providing enough opportunities for ARI to achieve its objectives. - Stuart Rothstein, CEO Q: How are you approaching the current cross currents in the commercial real estate market, and where do you see the best opportunities? A: We remain constructive on all forms of housing, including senior housing and student housing. We are cautious with office deals and focus on opportunities in the UK, Europe, and the US. We avoid ground-up development except for long-term lease data centers. - Scott Weiner, CIO Q: Is there any expectation for changes in the dividend policy, and what factors could prevent a dividend increase? A: There are no material tax protections against rising earnings, and the goal is to distribute as much of the earnings as possible as dividends. The policy is reviewed quarterly, and the aim is to maintain stability without frequent special dividends. - Stuart Rothstein, CEO For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
BrightSpire Capital Inc (BRSP) Q2 2025 Earnings Call Highlights: Navigating Challenges and ...
Release Date: July 30, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points BrightSpire Capital Inc (NYSE:BRSP) reported adjusted distributable earnings of $22.9 million or $0.18 per share, covering the dividend. The company made significant progress in reducing exposure to watch list loans, cutting it by 50% during the quarter. Net loan originations were positive for the quarter, with expectations for improved loan origination conditions in the second half of the year. The company repurchased 561,000 shares at an average price of $5.19, indicating confidence in its undervalued stock. BrightSpire Capital Inc (NYSE:BRSP) has a strong liquidity position with $325 million, including $106 million in unrestricted cash. Negative Points BrightSpire Capital Inc (NYSE:BRSP) reported a GAAP net loss attributable to common stockholders of $23.1 million or $0.19 per share. The company experienced a lull in new loan closings during the second quarter, impacting growth. There were challenges related to increased supply and tariff-related policy affecting the Ontario, California industrial loan. The Austin, Texas multi-family loan faced downward pressure on rental rates due to a supply glut in the market. The company's property operating margin declined, partly due to deferred maintenance expenses on foreclosed properties like the San Jose hotel. Q & A Highlights Warning! GuruFocus has detected 7 Warning Signs with BRSP. Q: Can you provide more details on the value-added activities for the San Jose hotel and multi-family properties in your REO portfolio? A: Mike Mazzi, CEO: For the San Jose hotel, we are addressing deferred maintenance issues, such as non-operational elevators, to prepare for upcoming major events like the Super Bowl and World Cup. We plan to invest capital over the next six months to improve the hotel's condition. Andy Witt, President and COO, added that for the multi-family properties, the focus is on addressing deferred maintenance, improving unit conditions, and enhancing curb appeal to achieve market occupancy. We expect to exit these assets over the next several quarters. Q: How has the bridge loan market evolved post-COVID, and what lessons have been learned? A: Mike Mazzi, CEO: The market has learned from the past bubble, and syndicators are largely gone, which is positive. We are now operating in a different rate environment with property values being reset. Current debt yields are better, and the capital markets are looking strong. We are optimistic about multi-family recovery and expect rent increases in 2026-2027. The market is lender-driven, with many refinancing opportunities ahead. Q: What is the potential for loan portfolio growth with your existing capital base? A: Andy Witt, President and COO: We have about $260 million in net book value in our REO portfolio and a healthy cash position. We believe the portfolio can grow to about $3.5 billion over time, depending on repayments and our ability to dispose of existing REO assets. Q: What is the repayment trajectory for the rest of 2025? A: Andy Witt, President and COO: We expect an uptick in repayments over Q2, with significant positions having a clear line of sight for resolution. While it's difficult to predict exact timing, we anticipate material resolutions in both the REO portfolio and loan repayments in the second half of the year. Q: How has the new Texas legislation on HFCs affected your strategy for existing and future loans? A: Mike Mazzi, CEO: The new legislation provides a two-year tax benefit unless we sell the assets. We plan to sell before this horizon, so it doesn't impact our strategy significantly. We are completing CapEx on the Fort Worth asset and expect to list it for sale in early 2026, followed by the Arlington asset in the second quarter of 2026. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
